Validation of a Multi-gene Test for Lung Cancer Risk
Trial status: Open for Enrollment
Why is this study being done?
Because more than 160,000 individuals die of lung cancer/year in the United States alone, it is important to use the best possible methods to determine whether increased surveillance of individuals at highest risk for lung cancer will result in reduced lung cancer mortality. The Lung Cancer Risk Test (LCRT) proposed for evaluation promises to accurately identify the 10-15% of the population that is most susceptible to lung cancer based on genetic predisposition. More than 90 million individuals in the United States alone are demographically at high risk for lung cancer and potential candidates for increased surveillance.
Who is eligible to participate?
- 20 or more pack year smoking history
- clinical need for diagnostic bronchoscopy
- Lung Cancer within 3 months after the date of enrollment